Nanjing Leads Biolabs (9887) Announces Inclusion in MSCI Global Small Cap Indexes

Bulletin Express
11/07

Nanjing Leads Biolabs Co., Ltd. (Stock Code: 9887) announced that its shares will be included in the MSCI Global Small Cap Indexes effective after the market close on November 24, 2025. This inclusion, compiled by Morgan Stanley Capital International, is designed to track the performance of smaller-capitalization companies in international markets.

According to the official announcement, the inclusion highlights investor recognition of Nanjing Leads Biolabs’ operating performance and potential for further development. Shareholders and potential investors are advised to exercise due care when trading the company’s shares. The board of directors reiterates that the inclusion in the MSCI Global Small Cap Indexes is a key milestone in the company’s ongoing growth and engagement with the global investment community.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10